Company: SUPN
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0001356576-25-000071
Chunk: 183

Company: SUPERNUS PHARMACEUTICALS, INC.
Filing Date: 2025-11-06
Form: 10-Q
Item: Part II, Item 6
Chunk 183
---
 to Item 601 of Regulation S-K. The Company agrees to furnish supplementally a copy of any omitted schedule to the SEC upon request.

64

Table of Contents

††            Certain portions of this exhibit that constitute confidential information have been omitted in accordance with Regulation S-K, Item 601(b) (10).

65

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.SUPERNUS PHARMACEUTICALS, INC.DATED: November 6, 2025By:/s/ Jack A. KhattarJack A. KhattarPresident and Chief Executive OfficerDATED: November 6, 2025By:/s/ Timothy C. DecTimothy C. DecSenior Vice-President and Chief Financial Officer

66